BioLineRx Ltd. (BLRX)
3.00
+0.19
(+6.76%)
USD |
NASDAQ |
Aug 24, 16:00
BioLineRx Price to Book Value : 0.7829 for Aug. 24, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| August 24, 2026 | 0.7829 |
| August 21, 2026 | 0.7334 |
| August 20, 2026 | 0.7203 |
| August 19, 2026 | 0.7647 |
| August 18, 2026 | 0.7438 |
| August 17, 2026 | 0.689 |
| August 14, 2026 | 0.7203 |
| August 13, 2026 | 0.7095 |
| August 12, 2026 | 0.702 |
| August 11, 2026 | 0.7242 |
| August 10, 2026 | 0.7078 |
| August 07, 2026 | 0.7073 |
| August 06, 2026 | 0.7281 |
| August 05, 2026 | 0.7091 |
| August 04, 2026 | 0.7203 |
| August 03, 2026 | 0.6934 |
| July 31, 2026 | 0.736 |
| July 30, 2026 | 0.7047 |
| July 29, 2026 | 0.7177 |
| July 28, 2026 | 0.7334 |
| July 27, 2026 | 0.7352 |
| July 24, 2026 | 0.736 |
| July 23, 2026 | 0.7464 |
| July 22, 2026 | 0.7434 |
| July 21, 2026 | 0.7621 |
| Date | Value |
|---|---|
| July 20, 2026 | 0.7386 |
| July 17, 2026 | 0.7568 |
| July 16, 2026 | 0.7777 |
| July 15, 2026 | 0.7595 |
| July 14, 2026 | 0.796 |
| July 13, 2026 | 0.809 |
| July 10, 2026 | 0.8064 |
| July 09, 2026 | 0.7908 |
| July 08, 2026 | 0.7856 |
| July 07, 2026 | 0.8239 |
| July 06, 2026 | 0.8239 |
| July 02, 2026 | 0.8573 |
| July 01, 2026 | 0.8273 |
| June 30, 2026 | 0.8143 |
| June 29, 2026 | 0.809 |
| June 26, 2026 | 0.826 |
| June 25, 2026 | 0.813 |
| June 24, 2026 | 0.8795 |
| June 23, 2026 | 0.8508 |
| June 22, 2026 | 0.8456 |
| June 18, 2026 | 0.8247 |
| June 17, 2026 | 0.7882 |
| June 16, 2026 | 0.796 |
| June 15, 2026 | 0.8469 |
| June 12, 2026 | 0.8795 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| XTL Biopharmaceuticals Ltd. | -- |
| Kamada Ltd. | 1.828 |
| Can-Fite BioPharma Ltd. | 2.447 |
| Galmed Pharmaceuticals Ltd. | 0.2390 |
| Revium Recovery, Inc. | -- |
Price to Book Value Related Metrics
| PS Ratio | 9.082 |
| PEG Ratio | -0.0014 |
| Price | 3.00 |
| Earnings Yield | -71.36% |
| Market Cap | 13.05M |
| PEGY Ratio | -0.0014 |